Supplements and Featured Publications
- Rethinking Heart Failure: Patient Classification and Treatment
- Volume 28
- Issue 14
Participating Faculty: Rethinking Heart Failure: Patient Classification and Treatment
Faculty
David L. Clark, MBA, BPharm
President
VisumRX, LLC
Portland, OR
Nihar R. Desai, MD, MPH
Vice Chief
Section of Cardiovascular Medicine
Yale New Haven Health System
New Haven, CT
Associate Professor
Yale School of Medicine
New Haven, CT
Gary M. Owens, MD
President
Gary Owens Associates
Ocean View, DE
Charles A. Stemple, DO, MBA
Medical Director (Former)
Humana
Cincinnati, OH
Faculty Disclosures
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months:
David L. Clark, MBA, BPharm
CONSULTANCIES OR PAID ADVISORY BOARDS:
Cytokinetics
Nihar R. Desai, MD, MPH
CONSULTANCIES OR PAID ADVISORY BOARDS:
Amgen, Boehringer Ingelheim, Bayer, Bristol Myers Squibb, Cytokinetics, Novartis, Vifor Pharma
GRANTS RECEIVED:
Amgen, Boehringer Ingelheim, Cytokinetics, Novartis, Vifor Pharma
LECTURE FEES FOR SPEAKING:
Amgen, Boehringer Ingelheim, Cytokinetics
Gary M. Owens, MD
CONSULTANCIES OR PAID ADVISORY BOARDS:
Cytokinetics, ICON
HONORARIA:
National Association of Managed Care Physicians
Charles A. Stemple, DO, MBA, reports no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this supplement.
Articles in this issue
almost 3 years ago
Rethinking Heart Failure: Patient Classification and TreatmentNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.